Differential activation of hepatic NF-κB in rats and hamsters by the peroxisome proliferators Wy-14,643, gemfibrozil, and dibutyl phthalate

Toxicological Sciences

Volumn 62, Issue 1, 2001, Pages 20-27

  Tharappel, Job C ^a   Cunningham, Michael L ^b   Spear, Brett T ^a   Glauert, Howard P ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Dibutyl phthalate; Gemfibrozil; Hamsters; NF B activation; Rats; Wy 14,643

Indexed keywords

CIPROFIBRATE; GEMFIBROZIL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEROXISOME PROLIFERATOR; PHTHALIC ACID DIBUTYL ESTER; PIRINIXIC ACID; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA BINDING; ELECTROPHORETIC MOBILITY; HAMSTER; LIVER; LIVER CARCINOGENESIS; MOUSE; NONHUMAN; OXIDATIVE STRESS; RAT; REGULATORY MECHANISM; SPECIES DIFFERENCE;

ANIMALS; CRICETINAE; DIBUTYL PHTHALATE; DNA; DNA-BINDING PROTEINS; ELECTROPHORESIS; GEMFIBROZIL; LIVER; MALE; MESOCRICETUS; NF-KAPPA B; OLIGONUCLEOTIDE PROBES; PEROXISOME PROLIFERATORS; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

ANIMALIA; CRICETINAE; MESOCRICETUS AURATUS;

EID: 0034964129     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/62.1.20     Document Type: Article

References (37)

1. Embryonic lethality and liver degeneration in mice lacking the Re1A component of NF-kappa B
2. Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators
3. Rapid activation of post-hepatectomy factor nuclear factor kappa B in hepatocytes, a primary response in the regenerating liver
4. A one-hour minipreparation technique for extraction of DNA-binding proteins from animal tissues
5. Peroxisomal enzyme activity and cell proliferation in rats, mice, and hamsters exposed for 13-weeks to Wy-14,643 and gemfibrozil
6. Hepatocellular DNA synthesis in rats given peroxisome proliferating agents: Comparison of WY-14,643 to clofibric acid, nafenopin, and LY171883
7. Peroxisome proliferation due to di(2-ethylhexyl) phthalate (DEHP): Species differences and possible mechanisms
8. Carcinogen bioassay and mutagenicity studies with the hypolipidemic agent gemfibrozil
9. Rapid DNA binding by nuclear factor kappa B in hepatocytes at the start of liver regeneration
10. Quantitative microscopy comparison of peroxisome proliferation by the lipid-regulating agent gemfibrozil in several species
11. Species differences in the clonal expansion of hepatocytes in response to the co-action of epidermal growth factor and nafenopin, a rodent hepatocarcinogenic peroxisome proliferator
12. Species differences in response to peroxisome proliferators correlate in vitro with induction of DNA synthesis rather than suppression of apoptosis
13. Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice
14. Mechanisms of hepatocarcinogenicity of peroxisome-proliferating drugs and chemicals
15. Comparison of the hepatic effects of nafenopin and WY-14,643 on peroxisome proliferation and cell replication in the rat and Syrian hamster
16. Comparative studies on nafenopin-induced hepatic peroxisome proliferation in the rat, Syrian hamster, guinea pig, and marmoset
17. Comparative studies on di-(2-ethylhexyl) phthalate-induced hepatic peroxisome proliferation in the rat and hamster
18. Treatment of rats with the peroxisome proliferator ciprofibrate results in increased liver NF-kappa B activity
19. Activation of nuclear factor-kappa B by the peroxisome proliferator ciprofibrate in H4IIEC3 rat hepatoma cells and its inhibition by the antioxidants N-acetylcysteine and vitamin E
20. Expression of the hydrogen peroxide-generating enzyme fatty acyl CoA oxidase activates NF-kappa B
21. 4-induced hepatic injury in mice is associated with inhibition of nuclear factor kappa B binding
22. 2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor
23. Liver-specific catalase expression in transgenic mice inhibits NF-kappa B activation and DNA synthesis induced by the peroxisome proliferator ciprofibrate
24. Technical report on the carcinogenesis bioassay of di(2-ethylhexyl) phthalate in F344 rats and B6C3F1 mice (feed studies)
25. Effects of peroxisome proliferators on glutathione and glutathione related enzymes in rats and hamsters
26. Effects of peroxisome proliferators on antioxidant enzymes and antioxidant vitamins in rats and hamsters
27. Time-dependence and differential induction of rat and guinea pig peroxisomal beta-oxidation, palmitoyl-CoA hydrolase, cytosolic and microsomal eopxide hydrolase after treatment with hypolipidemic drugs
28. Activators and target genes of Rel/NF-kappa B transcription factors
29. Peroxisome proliferation and hepatocarcinogenesis
30. Malignant tumors in rats fed nafenopin, a hepatic peroxisome proliferator
31. Mitogenic and carcinogenic effects of a hypolipidemic peroxisome proliferator, [4-chloro-6-(2,3-xylidino)]-2-pyrimidinylthiolacetic acid (Wy-14643), in rat and mouse liver
32. Hepatocellular carcinomas in acatalasemic mice treated with nafenopin, a hypolipidemic peroxisome proliferator
33. Apoptosis and proliferation in nongenotoxic carcinogenesis: Species differences and role of PPAR alpha
34. Toxicological studies in primates with three fibrates
35. Rel/NF-κB/Iκb family: Intimate tales of association and dissociation
36. The NF-kappa B/Rel and I kappa B gene families: Mediators of immune response and inflammation
37. Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis